Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Ribavirin for HFRS
NCT00868946Phase 2Withdrawn
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Oct 2009
- Primary completion
- Sep 2016
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 2 trial of ribavirin in hemorrhagic fever with renal syndrome (HFRS), sponsored by U.S. Army Medical Research and Development Command. Planned start Oct 2009; status: withdrawn.
02
Drugs
ribavirin
03
Conditions
hemorrhagic fever with renal syndrome (HFRS)
Beyond the preview
Go deeper on NCT00868946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00868946.